Administration of drugs known to inhibit P-glycoprotein increases brain bilirubin and alters the regional distribution of bilirubin in rat brain.
about
Genetic and epigenetic changes in host ABCB1 influences malaria susceptibility to Plasmodium falciparum.Exposure to lipopolysaccharide and/or unconjugated bilirubin impair the integrity and function of brain microvascular endothelial cellsTransport and metabolism at blood-brain interfaces and in neural cells: relevance to bilirubin-induced encephalopathy.Reduced expression of UGT1A1 in intestines of humanized UGT1 mice via inactivation of NF-κB leads to hyperbilirubinemia.Modulation of oral drug bioavailability: from preclinical mechanism to therapeutic application.The mitochondrial connection in auditory neuropathy.Fexofenadine hydrochloride in the treatment of allergic disease: a reviewEffect of ibuprofen on bilirubin-albumin binding during the treatment of patent ductus arteriosus in preterm infant.Placental ABC Transporters: Biological Impact and Pharmaceutical Significance.Induction of fetal hemoglobin and ABCB1 gene expression in 9-β-D-arabinofuranosylguanine-resistant MOLT-4 cells.The human multidrug-resistance-associated protein MRP1 mediates ATP-dependent transport of unconjugated bilirubinBilirubin accumulation and Cyp mRNA expression in selected brain regions of jaundiced Gunn rat pups.American Pediatric Society Presidential Address 2006: science on the edge with life in the balance.Membrane Transporters for Bilirubin and Its Conjugates: A Systematic Review.Modulation of bilirubin neurotoxicity by the Abcb1 transporter in the Ugt1-/- lethal mouse model of neonatal hyperbilirubinemia.The neuroprotective and anti-apoptotic effects of melatonin on hemolytic hyperbilirubinemia-induced oxidative brain damage.
P2860
Q33579831-86EF192A-4289-4EA4-BD6C-A9EAB2890146Q34269018-938CA36C-3F3B-4A08-929A-D5DCFBF7CE23Q35969947-30AD174B-6523-46A2-889A-FCC91EE28321Q36191283-196AC7CA-EF7E-432D-BB7D-5A664FBD7981Q36271954-1AA9BE58-F7F7-4119-A0B1-5A57A441F783Q37832364-C6BCFF30-B02D-4085-B0CA-878F9B651BFAQ37857671-5E8A71E9-250D-49A2-8CE3-9AC1987B7A4CQ37911530-6B32B16D-2F39-456C-9A34-0B473F369B4FQ38958745-000EF1C5-FAC5-4A2F-8817-6ECF00239F2FQ39627035-3BE0F660-87FB-4310-8157-465809CB2E2FQ40537617-47369D04-61B6-464A-85DD-551524BC4304Q45728938-8AE76B51-420E-407F-B7DC-1633A4955FC2Q46527471-B65ACC5D-8C10-422C-A517-F75689589DC5Q47272832-1A8E323F-E23C-418D-BF4E-26C17F13BD49Q48381016-DED0B9B1-C1D8-49C3-9907-F39BBD7BC86AQ52147437-8986248C-C959-4FC2-8A0A-5B553CB52FE2
P2860
Administration of drugs known to inhibit P-glycoprotein increases brain bilirubin and alters the regional distribution of bilirubin in rat brain.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Administration of drugs known ...... ion of bilirubin in rat brain.
@en
Administration of drugs known ...... ion of bilirubin in rat brain.
@nl
type
label
Administration of drugs known ...... ion of bilirubin in rat brain.
@en
Administration of drugs known ...... ion of bilirubin in rat brain.
@nl
prefLabel
Administration of drugs known ...... ion of bilirubin in rat brain.
@en
Administration of drugs known ...... ion of bilirubin in rat brain.
@nl
P2093
P2860
P1433
P1476
Administration of drugs known ...... ion of bilirubin in rat brain.
@en
P2093
Erik Hankø
Jon F Watchko
Steve Tommarello
Thor W R Hansen
P2860
P304
P356
10.1203/01.PDR.0000085169.87948.B6
P407
P577
2003-08-06T00:00:00Z
P5875
P6179
1030959083